The latest announcement is out from Diagnos ( (TSE:ADK) ).
DIAGNOS has opened its first U.S. office in Fort Lauderdale, Florida, as part of its growth strategy to expand its reach in the ophthalmic and optometry sectors. This move aligns with its strategic vision of meeting client needs and is accompanied by plans to hire local employees. Additionally, DIAGNOS is working on obtaining US FDA certification for its AI-assisted fundus image analysis platform, which is expected to advance healthcare professionals’ ability to diagnose diabetic retinopathy, hypertensive retinopathy, and age-related macular degeneration. The company has also engaged DS Market Solutions Inc. to enhance market depth and liquidity for its securities, while announcing the resignation of board member Francis Bellido.
More about Diagnos
DIAGNOS is a publicly traded Canadian corporation focused on the early detection of critical eye-related health problems. Utilizing Artificial Intelligence, the company aims to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes globally.
YTD Price Performance: -6.67%
Average Trading Volume: 208,323
Technical Sentiment Signal: Buy
Current Market Cap: C$28.52M
See more data about ADK stock on TipRanks’ Stock Analysis page.